Home/Filings/4/0001415889-25-006734
4//SEC Filing

Bergmann Anthony 4

Accession 0001415889-25-006734

CIK 0001133869other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 7:00 PM ET

Size

7.5 KB

Accession

0001415889-25-006734

Insider Transaction Report

Form 4
Period: 2025-03-03
Bergmann Anthony
CHIEF FINANCIAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2025-03-03$1.39/sh+2,500$3,4758,223 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-03-032,5000 total
    Exercise: $1.39Exp: 2025-03-03Common Stock (2,500 underlying)
Footnotes (2)
  • [F1]This option was granted on March 3, 2015 and was previously reported as covering 25,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020.
  • [F2]Shares vested 1/48th on the first day of each month commencing April 1, 2015.

Issuer

CAPRICOR THERAPEUTICS, INC.

CIK 0001133869

Entity typeother

Related Parties

1
  • filerCIK 0001593087

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:00 PM ET
Size
7.5 KB